| scholarly article | Q13442814 |
| P50 | author | Mari Mino-Kenudson | Q40930518 |
| P2093 | author name string | Douglas R Morgan | |
| Gregory Y Lauwers | |||
| Julie L Ryan | |||
| Margaret L Gulley | |||
| Ricardo L Dominguez | |||
| Sandra H Elmore | |||
| Leigh B Thorne | |||
| Jessica K Booker | |||
| P2860 | cites work | Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations | Q24670596 |
| Molecular diagnosis of Epstein-Barr virus-related diseases | Q24680502 | ||
| Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type | Q28268357 | ||
| An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformation | Q33825713 | ||
| Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines | Q34123922 | ||
| Towards a molecular approach to gastric cancer management | Q34341290 | ||
| Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors. | Q34350013 | ||
| Epstein-Barr virus-associated gastric carcinoma in Kazakhstan | Q34382480 | ||
| IL-1 receptor-associated kinase 1 is critical for latent membrane protein 1-induced p65/RelA serine 536 phosphorylation and NF-kappaB activation | Q34479733 | ||
| The future of gastric cancer prevention | Q34546719 | ||
| Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo | Q34553645 | ||
| The role of Epstein-Barr virus in cancer | Q34574840 | ||
| Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas | Q34605336 | ||
| Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors | Q34767204 | ||
| Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma | Q35045601 | ||
| Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation | Q35586343 | ||
| Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. | Q35587610 | ||
| Epstein-Barr virus-associated cancers: aetiology and treatment | Q35647396 | ||
| Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein | Q35764932 | ||
| A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease | Q35788728 | ||
| Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma | Q35789774 | ||
| Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs) | Q35849039 | ||
| Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer | Q35936801 | ||
| Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells | Q36135900 | ||
| Epstein Barr virus-associated tumours: an update for the attention of the working pathologist | Q36172481 | ||
| In situ detection of Epstein-Barr virus and phenotype determination of EBV-infected cells. | Q36509134 | ||
| Laboratory assays for Epstein-Barr virus-related disease | Q37192117 | ||
| Molecular diagnosis of Epstein-Barr virus in paraffin-embedded tissues of tumors with abundant lymphoid infiltration. | Q38452662 | ||
| Induction of Id1 and Id3 by latent membrane protein 1 of Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent kinase 2 in rodent fibroblast transformation | Q40487971 | ||
| Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas | Q40594969 | ||
| Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA | Q40617465 | ||
| The antibody 2B4 directed against the Epstein-Barr virus (EBV)-encoded nuclear antigen 1 (EBNA1) detects MAGE-4: implications for studies on the EBV association of human cancers. | Q43700357 | ||
| Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. | Q43931328 | ||
| Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras | Q44055169 | ||
| Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan | Q44174724 | ||
| The control of lytic replication of Epstein-Barr virus in B lymphocytes (Review). | Q44410087 | ||
| Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia. | Q44469385 | ||
| EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. | Q44765700 | ||
| Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. | Q44789849 | ||
| Epstein-Barr virus-positive multiple early gastric cancers and dysplastic lesions: a case report | Q44839906 | ||
| Association of Helicobacter pylori and Epstein-Barr virus with gastric cancer and peptic ulcer disease | Q45394256 | ||
| Evaluation of epstein-barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay | Q45590622 | ||
| Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan. | Q45605844 | ||
| The Epstein Barr virus and gastric carcinoma. | Q45664227 | ||
| Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma | Q45667663 | ||
| Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy | Q45710801 | ||
| Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes | Q45710982 | ||
| Recurrent genomic aberrations in gastric carcinomas associated with Helicobacter pylori and Epstein-Barr virus | Q45731027 | ||
| Detection of Epstein-Barr virus genome within thymic epithelial tumours in Taiwanese patients by nested PCR, PCR in situ hybridization, and RNA in situ hybridization | Q45731089 | ||
| Demonstration of Epstein-Barr virus in carcinomas of various sites | Q45731119 | ||
| High prevalence of Epstein-Barr virus in gastric remnant carcinoma after Billroth-II reconstruction | Q45731252 | ||
| Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma | Q45734089 | ||
| Epstein-Barr virus in gastric carcinoma is associated with location in the cardia and with a diffuse histology: a study in one area of Chile | Q45734458 | ||
| Low prevalence of latently Epstein-Barr virus-infected cells in chronic gastritis | Q45735884 | ||
| Circulating Epstein-Barr virus DNA in the serum of patients with gastric carcinoma | Q45736526 | ||
| Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients | Q45738116 | ||
| Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach | Q45744646 | ||
| Detection of latent Epstein-Barr virus (EBV) DNA in paraffin sections of nasopharyngeal carcinomas expressing no EBV-encoded small RNAs using in situ PCR. | Q45754702 | ||
| Epstein-Barr virus infection in non-carcinomatous gastric epithelium | Q45758646 | ||
| Epstein-Barr virus in gastric carcinoma in Suzhou, China and Osaka, Japan: association with clinico-pathologic factors and HLA-subtype | Q45763269 | ||
| Epstein-Barr virus and gastric remnant cancer | Q45781006 | ||
| Epstein-Barr virus and Hodgkin's disease: a comparative immunological, in situ hybridization, and polymerase chain reaction study. | Q45783087 | ||
| A Rapid and Reliable Enzyme Immunoassay PCR-Based Screening Method to Identify EBV-Carrying Gastric Carcinomas | Q58381765 | ||
| Gastric carcinoma with lymphoid stroma: incidence of EBV and Helicobacter pylori infection | Q73460058 | ||
| Epstein-Barr virus and gastric carcinoma | Q77951202 | ||
| LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice | Q81398990 | ||
| P433 | issue | 1 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| adenocarcinoma | Q356033 | ||
| gastric adenocarcinoma | Q18556047 | ||
| P304 | page(s) | 80-90 | |
| P577 | publication date | 2008-11-10 | |
| P1433 | published in | Laboratory Investigation | Q6467260 |
| P1476 | title | High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma | |
| P478 | volume | 89 |
| Q37213462 | Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer |
| Q36720261 | Assessment of Epstein-Barr virus nucleic acids in gastric but not in breast cancer by next-generation sequencing of pooled Mexican samples |
| Q58710575 | Associations of Epstein-Barr Virus-Positive Gastric Adenocarcinoma with Circulating Mediators of Inflammation and Immune Response |
| Q36847178 | Atypical Epstein-Barr viral genomic structure in lymphoma tissue and lymphoid cell lines |
| Q37653908 | Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer |
| Q35550673 | Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia |
| Q45324790 | Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal. |
| Q33709895 | Clinical utility of circulating cell-free Epstein-Barr virus DNA in patients with gastric cancer |
| Q41170298 | Construction and identification of recombinant lentiviral vector containing HIV-1 Tat gene and its expression in 293T cells |
| Q39455578 | Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma |
| Q41696845 | Detection and quantification of EBV, HHV-6 and CMV DNA in the gastrointestinal tract of HIV-positive patients |
| Q47551595 | Elevated Levels of Interferon-γ Are Associated with High Levels of Epstein-Barr Virus Reactivation in Patients with the Intestinal Type of Gastric Cancer |
| Q57010907 | Epstein-Barr Virus-Positive Cancers Show Altered B-Cell Clonality |
| Q43521606 | Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases |
| Q38766316 | Epstein-Barr virus gene expression and latency pattern in gastric carcinomas: a systematic review |
| Q37160213 | Epstein-Barr virus-associated gastric carcinoma in Brazil: comparison between in situ hybridization and polymerase chain reaction detection. |
| Q36687528 | Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profile |
| Q37566742 | Evidence of Epstein-Barr virus association with gastric cancer and non-atrophic gastritis. |
| Q86054502 | Expression of EBV-encoded oncogenes and EBV-like virions in multiple canine tumors |
| Q40764983 | Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns |
| Q36972101 | Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America |
| Q27024034 | Genomic assays for Epstein-Barr virus-positive gastric adenocarcinoma |
| Q42271409 | Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus |
| Q35258785 | Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. |
| Q44418746 | Meta-analysis of the relationship between Epstein-Barr virus infection and clinicopathological features of patients with gastric carcinoma |
| Q64104346 | Novel Therapeutics for Epstein⁻Barr Virus |
| Q90064455 | Positive Status of Epstein-Barr Virus as a Biomarker for Gastric Cancer Immunotherapy: A Prospective Observational Study |
| Q45325453 | The conundrum of the Epstein-Barr virus-associated gastric carcinoma in the Americas |
| Q40066662 | The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification. |
| Q41594529 | Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation |
| Q37726624 | Using Epstein-Barr viral load assays to diagnose, monitor, and prevent posttransplant lymphoproliferative disorder |
| Q36399985 | Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas |
| Q40321142 | Variation in risk and outcomes of Epstein-Barr virus-associated breast cancer by epidemiologic characteristics and virus detection strategies: an exploratory study |
| Q34135741 | Viral hit and run-oncogenesis: Genetic and epigenetic scenarios |
| Q61807565 | Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma |
| Q93009183 | Virus expression detection reveals RNA-sequencing contamination in TCGA |
Search more.